Condition

Neoadjuvant Immunotherapy clinical trials and research

• 6Clinical trials
• 2Countries

Newest Neoadjuvant Immunotherapy clinical trials

All recruiting trials (6)

• Neoadjuvant Cemiplimab for Merkel Cell Carcinoma in Stage I–II

  This study tests whether giving Cemiplimab before surgery helps people with early-stage Merkel cell carcinoma see if tumors shrink or disappear before sentinel node biopsy.

  Recruiting at 11 sites Phase 2 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · Heidelberg, Baden-Wurttemberg and 11 other locations · NCT07387198

• Evaluating neoadjuvant immunotherapy for lung cancer treatment outcomes

  This study is trying to see if giving immunotherapy before surgery helps people with non-small cell lung cancer live longer and feel better.

  Recruiting at 4 sites Peking University Cancer Hospital & Institute · Beijing, Beijing Municipality and 3 other locations · NCT06926179

• Combining low dose radiotherapy with immunotherapy and chemotherapy for lung cancer treatment

  This study is testing whether a combination of low dose radiation, immunotherapy, and chemotherapy can help people with stage II-III non-small cell lung cancer do better before surgery.

  Recruiting Phase 2 Anhui Provincial Cancer Hospital · Hefei, Anhui · NCT06714708

• Using 68Ga-grazytracer PET imaging to evaluate immunotherapy in lung cancer

  This study is testing if a special type of PET imaging can help doctors see how well immunotherapy is working for patients with stage III non-small cell lung cancer.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06623487

• Neoadjuvant therapy for cervical cancer with fertility preservation

  This study is testing a new combination of treatments for women with early-stage cervical cancer to see if it can shrink tumors enough to allow for surgery that preserves their ability to have children.

  Recruiting Phase 2 Fudan University · Shanghai, Shanghai Municipality · NCT06209294

• Using Tislelizumab and Disitamab-vedotin for Neoadjuvant Therapy in High-risk Upper Tract Urothelial Carcinoma

  This study is testing a new combination of two drugs, tislelizumab and disitamab-vedotin, to see if they can safely help people with high-risk upper tract urothelial carcinoma before surgery, especially for those who can't take traditional chemotherapy.

  Recruiting Phase 2 Tianjin Medical University Second Hospital · Tianjin · NCT05837806

Related topics

Quick answers

How many Neoadjuvant Immunotherapy clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (5 trials), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →